STAT1 min citite
STAT+: Pharmalittle: U.K. Regulator To Streamline Clinical Trial Approvals; NIH Won’t Seize Patents To Cut Price Of Cancer Drug
The NIH rejected a petition urging the agency to use a controversial provision of federal law to widen access to a cancer drug by forcing the manufacturers to license their…
STAT1 min citite
STAT+: Pharmalittle: FDA Official Wants To Use Accelerated Approval For Gene Therapies; Pharma Asks Biden For Tax Breaks In The Semiconductor Package
A top FDA official says the agency needs to start using accelerated approval to advance gene therapies for rare diseases.
STAT1 min citite
Opinion: Americans Should Be Able To Register To Vote When They Apply For Health Insurance On
Voter registration on should be available when Americans begin applying for health insurance this fall, ahead of Election Day 2024.
STAT1 min citite
Opinion: The Lab Leak Conversation Shows It’s Time To Rethink Our Biosecurity Infrastructure, Not Just Policies
With biosecurity at the forefront of people’s minds, this is an opportune moment to think differently.
STAT1 min citite
STAT+: Pharmalittle: Manufacturers Say Bird Flu Shots For Humans Can Be Made Quickly; Obesity Guidelines For Children Disappoint
Makers of flu vaccines say they could manufacture hundreds of millions of bird flu shots for humans within months if a new strain jumps the species divide.
STAT1 min citite
STAT+: Pharmalittle: Sanofi Cuts Price On A Popular Insulin By 78%; Califf Criticizes Insurers For Doing Too Little On Drug Research
FDA Commissioner Robert Califf wants private insurers to chip in on doing post-approval clinical research on drugs.
STAT2 min citite
STAT+: Pharmalittle: Alzheimer’s Group Starts Lobbying For Medicare To Cover New Drug; U.S. Judge Seems Sympathetic To Abortion-pill Challenge
The federal judge who could upend access to an abortion medication pressed government lawyers in a hearing about the safety and approval process for the drug.
STAT1 min citite
STAT+: Pharmalittle: Novo To Cut Some Insulin Prices By Up To 75%; Veterans Administration To Cover New Alzheimer’s Treatment
Under mounting pressure, Novo Nordisk plans to cut U.S. list prices for several insulin products by up to 75%, the latest big drugmaker to take such a step.
STAT1 min citite
STAT+: Pharmalittle: Biogen Exec Who Quarterbacked Aduhelm Leaves; Pfizer To Buy Seagen For $43 Billion
The Biogen senior executive who supervised the development and controversial approval of the Alzheimer’s treatment Aduhelm left the company last week.
STAT1 min citite
STAT+: Pharmalittle: New York Officials Press Pharmacy Chains Over Abortion Pill; Sanders Pushes Bill For $20 Insulin Cap
New legislation introduced by Sen. Bernie Sanders would prohibit all insulin manufacturers from charging more than $20 per vial.
STAT1 min citite
STAT+: Pharmalittle: Pharmacies Are Battlegrounds In The Abortion Debate; Lilly Alzheimer’s Drug Failed To Prevent Memory Loss In Study
An experimental Eli Lilly drug failed to prevent memory loss in a study of healthy older people with a high risk of developing clinical Alzheimer’s disease.
STAT1 min citite
STAT+: Pharmalittle: FDA Head Wants To Get Rid Of Advisory Panel Votes; Premature-birth Drug Is Finally Withdrawn
FDA Commissioner Robert Califf would like to get rid of voting at the end of advisory committee meetings "as much as possible."
STAT1 min citite
STAT+: Pharmalittle: Biden Proposes Expanding Medicare Drug-price Negotiation; Weight Watchers Moves Into Obesity Drug Market
The White House will propose expanding authority to negotiate what Medicare pays for more drugs than the limited number approved last year.
STAT7 min citite
STAT+: Foundation Charges Cancer Patients $83,000 For Unproven But Promising Experimental Drug
It has been more than 11 years since Julia Young was diagnosed with advanced ovarian cancer, and two years since it spread to her lymph system. By her own account,…
STAT1 min citite
STAT+: Pharmalittle: Walgreens Won’t Dispense Abortion Pills In Several States; Lilly Avoids Paying Medicaid Rebates With Insulin Price Cuts
Walgreens won't dispense abortion pills in several states where they remain legal amid threats from state officials and pressure from anti-abortion activists.
STAT1 min citite
STAT+: Pharmalittle: How Lilly’s Cuts Will Affect Other Efforts To Lower Insulin Prices; Pharma Rebukes U.K. Over Clawbacks
Lilly's slashing of prices for some of its insulin products raised questions about what will happen to other efforts to provide low-cost insulin.
STAT1 min citite
STAT+: Pharmalittle: FDA Panel Backs A GSK Vaccine For RSV; Opioid Wholesalers Cleared Of Liability To Georgia Families
A FDA advisory panel backed a GSK respiratory syncytial virus vaccine, setting it up for a race with Pfizer to have the first approved U.S. shot against RSV.
STAT1 min citite
STAT+: Pharmalittle: Eli Lilly Cuts Prices For Some Insulin Products; Congressional Committee Opens Probe Into PBMs
House Republicans have launched an investigation into PBMs, dialing up the scrutiny of the middlemen who play an important role in how much medicines cost.
STAT1 min citite
STAT+: Pharmalittle: Pfizer In Talks To Acquire Seagen; U.S. Trade Rep Urged Not To Sanction Countries That Sidestep Vertex Patents
Pfizer is in talks to acquire Seagen, the latest potential deal for a big drug company aimed at adding a promising class of targeted cancer therapies.
STAT1 min citite
STAT+: Pharmalittle: Moderna Pays NIH For Covid Vaccine Technique; First Trial Over Zantac Cancer Claims Is Postponed
Moderna has paid $400 million to the U.S. government for the rights to a chemical technique used in its successful Covid-19 vaccines.
STAT1 min citite
STAT+: Pharmalittle: Looming Abortion Pill Ruling Could Undermine Drug Approval System; Medicare Says No To Changing Alzheimer’s Drug Restrictions
A court challenge to approval of mifepristone could set a sweeping precedent that might undermine the infrastructure for evaluating all drugs.
STAT4 min citite
STAT+: More Physicians Are Calling For Fallopian Tube Removal To Prevent Ovarian Cancer
Some doctors recommend that women who are done with childbearing, and undergoing other pelvic surgeries, have their tubes removed.
STAT1 min citite
STAT+: Pharmalittle: Cystic Fibrosis Patients Caught In Battle Between Pharma And Insurers; Merck Covid Pill Fails To Prevent Infection Among Household Members
Cystic fibrosis patients and their families are getting caught in the middle of a struggle between Vertex and insurers over copays.
STAT1 min citite
STAT+: Pharmalittle: Pfizer Scraps Half Of Participants In Lyme Vaccine Trial Over Quality Issues; Ginkgo CEO May Have Possible Conflict Of Interest
Pfizer discontinued a significant percentage of participants in a study testing a Lyme vaccine due to violations at trial sites run by a third party.
STAT1 min citite
STAT+: Pharmalittle: Biden Administration Pitches Three Drug-pricing Experiments; GSK Kept Quiet On Zantac Cancer Risk
Over four decades, GSK chose to keep quiet on the cancer risks of the recalled heartburn medication Zantac.
STAT1 min citite
STAT+: Pharmalittle: Biotech Is In Shake-out Mode; Sanofi R&D Head Jumps To Johnson & Johnson
The biotech industry is in shake-out mode after the ranks of public drug developers swelled in recent years amid an IPO boom.
STAT1 min citite
STAT+: Pharmalittle: Sanofi R&D Head Unexpectedly Steps Down; U.K. Tax Rate Criticized After AstraZeneca Locates Plant In Ireland
Sanofi says its global head of research and development, John Reed, is stepping down after shareholders criticized its development pipeline.
STAT1 min citite
STAT+: Pharmalittle: Generic Drugmakers May Be Helped By Inflation Reduction Act; Bayer Union Warns Not To Split The Company
A German union opposes splitting up Bayer after the departure of its chief executive and warned the company should not bow to pressure from hedge fund activism.
STAT1 min citite
STAT+: Pharmalittle: Study Of Covid-19 Therapy Revives Debate Over FDA Clearance; Pharma Companies Are Ready To Make Deals
A new class of treatments for Covid-19 variants could help restock the country’s armory but faces an uncertain road to the commercial market.
STAT1 min citite
STAT+: Pharmalittle: Biden To Call For Expanding Caps On Insulin Prices; Families Seek To Override Vertex CF Drug Patents In Organized Campaign
In a bid to expand access to pricey cystic fibrosis treatments, a coalition of families and activists is petitioning four governments to make it possible to obtain generic versions of…
... Sau descoperiți ceva nou